1. Efficacy and safety of Paxlovid for COVID-19:a meta-analysis;Qian;J Infect,2022
2. Minimum manufacturing costs, national prices, and estimated global availability of new repurposed therapies for Coronavirus Disease 2019;Junzheng;Open Forum Infect Dis,2022
3. Efficacy and safety of molnupiravir for COVID-19 patients;Maurish;Eur J Intern Med,2022
4. Accelerating clinical evaluation of repurposed combination therapies for COVID-19;Rayner Craig;Am J Trop Med Hyg,2020
5. Fluvoxamine: a review of its mechanism of action and its role in COVID-19;Sukhatme Vikas;Front Pharmacol,2021